dopamine: be contraindicated in hypovolemic shock

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents neurotransmitter
Weight: 0.73
, chemical
Weight: 0.69
, hormone
Weight: 0.68
, neuron
Weight: 0.67
, drug
Weight: 0.67
Siblings acetylcholine
Weight: 0.41
, serotonin
Weight: 0.41
, vasopressin
Weight: 0.39
, oxytocin
Weight: 0.39
, norepinephrine
Weight: 0.38

Related properties

Property Similarity
be contraindicated in hypovolemic shock 1.00
be contraindicated in shock 0.99
be contraindicated in pheochromocytoma 0.92
be used in cardiogenic shock 0.82
be given for cardiovascular shock 0.77
be prefered over adrenaline in cardiogenic shock 0.77
be used for bradycardia 0.77
be used in shock 0.75

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.04
Rule weight: 0.13
Evidence weight: 0.36
Similarity weight: 0.75
Evidence: 0.78
¬ Remarkable(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.82
¬ Remarkable(vasopressin, be used in shock)

Remarkability from sibling implausibility

0.42
Rule weight: 0.60
Evidence weight: 0.93
Similarity weight: 0.75
Evidence: 0.60
Plausible(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.82
Remarkable(vasopressin, be used in shock)
Evidence: 0.94
¬ Plausible(vasopressin, be used in shock)

Salient implies Plausible

0.20
Rule weight: 0.28
Evidence weight: 0.70
Similarity weight: 1.00
Evidence: 0.60
Plausible(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.75
¬ Salient(dopamine, be contraindicated in hypovolemic shock)

Similarity expansion

0.70
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.99
Evidence: 0.78
Remarkable(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.79
¬ Remarkable(dopamine, be contraindicated in shock)
0.70
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.99
Evidence: 0.75
Salient(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.73
¬ Salient(dopamine, be contraindicated in shock)
0.68
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.92
Evidence: 0.78
Remarkable(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.61
¬ Remarkable(dopamine, be contraindicated in pheochromocytoma)
0.66
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.92
Evidence: 0.75
Salient(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.63
¬ Salient(dopamine, be contraindicated in pheochromocytoma)
0.65
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.99
Evidence: 0.60
Plausible(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.58
¬ Plausible(dopamine, be contraindicated in shock)
0.65
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.99
Evidence: 0.55
Typical(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.52
¬ Typical(dopamine, be contraindicated in shock)
0.62
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.82
Evidence: 0.55
Typical(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.23
¬ Typical(dopamine, be used in cardiogenic shock)
0.61
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.77
Evidence: 0.78
Remarkable(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.33
¬ Remarkable(dopamine, be given for cardiovascular shock)
0.61
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.77
Evidence: 0.75
Salient(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.26
¬ Salient(dopamine, be used for bradycardia)
0.61
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.92
Evidence: 0.60
Plausible(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.56
¬ Plausible(dopamine, be contraindicated in pheochromocytoma)
0.61
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.77
Evidence: 0.78
Remarkable(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.35
¬ Remarkable(dopamine, be used for bradycardia)
0.61
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.77
Evidence: 0.75
Salient(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.34
¬ Salient(dopamine, be given for cardiovascular shock)
0.60
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.82
Evidence: 0.75
Salient(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.58
¬ Salient(dopamine, be used in cardiogenic shock)
0.59
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.82
Evidence: 0.60
Plausible(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.39
¬ Plausible(dopamine, be used in cardiogenic shock)
0.59
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.77
Evidence: 0.60
Plausible(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.26
¬ Plausible(dopamine, be used for bradycardia)
0.57
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.77
Evidence: 0.78
Remarkable(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.59
¬ Remarkable(dopamine, be prefered over adrenaline in cardiogenic shock)
0.57
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.92
Evidence: 0.55
Typical(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.59
¬ Typical(dopamine, be contraindicated in pheochromocytoma)
0.57
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.82
Evidence: 0.78
Remarkable(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.86
¬ Remarkable(dopamine, be used in cardiogenic shock)
0.55
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.77
Evidence: 0.60
Plausible(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.41
¬ Plausible(dopamine, be given for cardiovascular shock)
0.55
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.77
Evidence: 0.55
Typical(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.36
¬ Typical(dopamine, be used for bradycardia)
0.54
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.75
Evidence: 0.78
Remarkable(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.73
¬ Remarkable(dopamine, be used in shock)
0.54
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.75
Evidence: 0.75
Salient(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.64
¬ Salient(dopamine, be used in shock)
0.53
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.75
Evidence: 0.55
Typical(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.39
¬ Typical(dopamine, be used in shock)
0.51
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.77
Evidence: 0.75
Salient(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.90
¬ Salient(dopamine, be prefered over adrenaline in cardiogenic shock)
0.50
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.77
Evidence: 0.55
Typical(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.55
¬ Typical(dopamine, be given for cardiovascular shock)
0.43
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.77
Evidence: 0.60
Plausible(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.85
¬ Plausible(dopamine, be prefered over adrenaline in cardiogenic shock)
0.42
Rule weight: 0.85
Evidence weight: 0.65
Similarity weight: 0.75
Evidence: 0.60
Plausible(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.88
¬ Plausible(dopamine, be used in shock)
0.39
Rule weight: 0.85
Evidence weight: 0.59
Similarity weight: 0.77
Evidence: 0.55
Typical(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.90
¬ Typical(dopamine, be prefered over adrenaline in cardiogenic shock)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.89
Similarity weight: 1.00
Evidence: 0.75
Salient(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.55
¬ Typical(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.78
¬ Remarkable(dopamine, be contraindicated in hypovolemic shock)

Typical implies Plausible

0.37
Rule weight: 0.48
Evidence weight: 0.78
Similarity weight: 1.00
Evidence: 0.60
Plausible(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.55
¬ Typical(dopamine, be contraindicated in hypovolemic shock)

Typicality and Rermarkability incompatibility between siblings

0.07
Rule weight: 0.14
Evidence weight: 0.64
Similarity weight: 0.75
Evidence: 0.78
¬ Remarkable(dopamine, be contraindicated in hypovolemic shock)
Evidence: 0.46
¬ Typical(vasopressin, be used in shock)